Guggenheim Capital’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Guggenheim Capital’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,405	Closed	-$3K	–	3075
2016 Q3	$3K	Sell	21,405 -460	-2%	-$106	﹤0.01%	2881
2016 Q2	$7K	Hold	21,865	–	–	﹤0.01%	2861
2016 Q1	$4K	Buy	+21,865	New	+$6.07K	﹤0.01%	2899

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Guggenheim Capital's TLOG Position: Q4 2016 in Review

Guggenheim Capital sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 21,405 shares — an estimated $3K sold.

Guggenheim Capital first reported a position in TLOG in Q1 2016 and held it in 3 quarters. The position peaked at $7K in Q2 2016. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Guggenheim Capital reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Guggenheim Capital sold 21,405 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $3K.
Guggenheim Capital first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2016 and held it in 3 quarters.
Guggenheim Capital's TetraLogic Pharmaceuticals Corporation position peaked at $7K in Q2 2016.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Guggenheim Capital's 13F filing for Q4 2016, filed 14 Feb 2017.